SWS Medical: Pioneering Innovation in China’s Blood Purification Industry

Release time: Dec 12 11:59:26, 2024


Group photo of SWS Dialysis' guests

 

During the early December 2024 Equipment Manufacturing Industry Development Conference, Xin Guobin, Vice Minister of the Ministry of Industry and Information Technology of the Peoples Republic of China, visited SWS Medical in Chongqing. As the first enterprise listed on Chongqings Science and Technology Innovation Board and a pioneering player in Chinas high-end medical equipment manufacturing industry, SWS Medicalwas highlighted for its significance as a model for the industrialization of industrial innovation achievements.

 

Vice Minister Xin Guobins visit not only recognized SWS Medicals strengths in innovation but also demonstrated the Ministry of Industry and Information Technologys commitment to elevating domestic enterprises in the medical equipment sector, a key department for implementing high-quality development actions for key industrial chains and promoting major scientific and technological projects.

Touring the production line of blood purification consumables

 

During his visit, Vice Minister Xin received a comprehensive overview that included presentations on SWS Medicals major national scientific and technological research projects, as well as an update on new blood purification product development.

 

While touring the blood purification consumables production line, Chairman Gao highlighted the SD series hemodialyzers produced by Dialife, a subsidiary of SWS Medical.

 

 Our unique steam sterilization process offers superior biocompatibility compared to other sterilization methods used by competing brands," said Chairman Gao.

 

This innovation was highly praised by the officials from the Ministry of Industry and Information Technology. Vice Minister Xin remarked, "As the first listed company on the Science and Technology Innovation Board in Chinas blood purification industry, SWS Medicals product quality is continually improving, allowing it to gain more competitive advantages globally. This reflects the companys significant role in the nations healthcare innovation landscape.

Indeed, in the third quarter of 2024, SWS Medical held a 20% market share for hemodialysis machines and 23.5% for continuous blood purification equipment (CRRT), positioning it as the dialysis industry leader and top exporter in China (Data source: Todays Bidding Information).

 

Based in Chongqing, SWS Medical is a prominent global provider of innovative medical products and services. Its offerings include advanced blood purification devices, high-quality disposables, intelligent dialysis management systems, and a network of dialysis centers. SWS Medical is uniquely positioned with a comprehensive blood purification industrial chain, chairs the China Blood Purification Industry Technology Innovation Strategic Alliance, and leads the development of national and industry standards. Publicly traded on the STAR Market(SSE: 688410), its devices hold CE markings and comply with ISO 13485:2016 standards. The company owns multiple national-level scientific and technological innovation platforms, such as the National Enterprise Technology Center, the National Local Joint Engineering Center, and the National Demonstration and Innovation Enterprise.